In addition, T2D patients exhibited lower responses to Dex-induced effects on GILZ and FKBP5 expression compared to healthy individuals, further supporting the presence of GC resistance in PBMCs of T2D patients [126]. The gene discussed is TSC22D3; the disease is type 2 diabetes mellitus.